Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 2/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | MIF | P14174 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2181944 | 0.94 | CA1 (0.52) | CA1CA2MMEZDHHC7KMT2A | |
| SCHEMBL5000153 | 0.86 | CA1 (0.47) | CA1CA2MMEZDHHC7KMT2A | |
| SCHEMBL27846410 | 0.85 | CA2 (0.74) | CA1CA2MMEZDHHC7TSHR | |
| SCHEMBL5696619 | 0.85 | CA2 (0.74) | CA1CA2ZDHHC7KMT2ATSHR | |
| SCHEMBL27768349 | 0.83 | CA2 (0.66) | CA1CA2ZDHHC7KMT2AMEN1 | |
| SCHEMBL25909345 | 0.82 | CA2 (0.63) | CA1CA2ZDHHC7KMT2AMEN1 | |
| SCHEMBL701087 | 0.82 | CA2 (0.63) | CA1CA2ZDHHC7KMT2AMEN1 | |
| SCHEMBL14012605 | 0.81 | — | — | |
| SCHEMBL5000143 | 0.81 | CPB2 (0.47) | CA1CA2KMT2AMEN1CYP4A11 | |
| SCHEMBL10612507 | 0.80 | CA1 (0.47) | CA1CA2MMEZDHHC7KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114989438-A | Polyester dendritic polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-09-02 | — | — | CN | claimed |
| US-7241914-B2 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-10 | — | — | US | claimed |
| US-20050148802-A1 | Method for producing polyetherols | BASF AKTIENGESELLSCHAFT | 2005-07-07 | — | — | US | claimed |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-13 | — | — | US | claimed |
| CN-114989438-A | Polyester dendritic polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-09-02 | — | — | CN | disclosed |
| US-20170327626-A1 | METHOD FOR PRODUCING RADIATION-CURABLE URETHANE (METH)ACRYLATES | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NASA | 2017-11-16 | — | — | US | disclosed |
| US-7420013-B2 | Mixtures of compounds comprising at least two double bonds and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-02 | — | — | US | disclosed |
| US-7250481-B2 | Reacting polyalcohol with at least one ethylenically unsaturated carboxylic acid in the presence of at least one esterification catalyst and of at least one polymerization inhibitor, polymerizing the reaction mixture, in the presence of at least one radical initiator, postcrosslinking, drying | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-31 | — | — | US | disclosed |
| US-7241914-B2 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-10 | — | — | US | disclosed |
| US-20070129564-A1 | Method for the production of (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-07 | — | — | US | disclosed |
| US-20060235141-A1 | Mixtures of compounds comprising at least two double bonds and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-19 | — | — | US | disclosed |
| US-20060052571-A1 | Method for the production of radiation-curable urethane (meth) acrylates | BASF AKITIENGESELLSCHAFT (DE) | 2006-03-09 | — | — | US | disclosed |
| US-20050203268-A1 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-15 | — | — | US | disclosed |
| US-20050176910-A1 | Method for the production of esters of polyalcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-11 | — | — | US | disclosed |
| US-20050148802-A1 | Method for producing polyetherols | BASF AKTIENGESELLSCHAFT | 2005-07-07 | — | — | US | disclosed |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129564-A1 | Method for the production of (meth)acrylic acid esters | MMAB, ACR, MCCC2 | CA1 2048/4885CA2 3918/4885MME 1908/4885 |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | ADH1A, ADH1C, ADH5 | CA1 700/4885CA2 3346/4885MME 1035/4885 |
| US-20050148802-A1 | Method for producing polyetherols | ADH1A, ADH1C, ADH5 | CA1 1429/4885CA2 3577/4885MME 2495/4885 |
| US-20050203268-A1 | Method for producing polyesterpolyols of polyvalent alcohols | ADH1C, ADH1A, ADH5 | CA1 540/4885CA2 1204/4885MME 2517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.